Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.

The role of PI3K signaling pathway in Alzheimer’s disease

Open access
Pan, Jingying, Yao, Qi, Wang, Yankai, Chang, Suyan, Li, Chenlong, Wu, Yongjiang, Shen, Jianhong, Yang, Riyun · 2024 · Frontiers in Aging Neuroscience

Abstract

Alzheimer’s disease (AD) is a debilitating progressively neurodegenerative disease. The best-characterized hallmark of AD, which is marked by behavioral alterations and cognitive deficits, is the aggregation of deposition of amyloid-beta (Aβ) and hyper-phosphorylated microtubule-associated protein Tau. Despite decades of experimental progress, the control rate of AD remains poor, and more precise deciphering is needed for potential therapeutic targets and signaling pathways involved. In recent years, phosphoinositide 3-kinase (PI3K) and Akt have been recognized for their role in the neuroprotective effect of various agents, and glycogen synthase kinase 3 (GSK3), a downstream enzyme, is also crucial in the tau phosphorylation and Aβ deposition. An overview of the function of PI3K/Akt pathway in the pathophysiology of AD is provided in this review, along with a discussion of recent developments in the pharmaceuticals and herbal remedies that target the PI3K/Akt signaling pathway. In conclusion, despite the challenges and hurdles, cumulative findings of novel targets and agents in the PI3K/Akt signaling axis are expected to hold promise for advancing AD prevention and treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnagi.2024.1459025

Cites

169 of 169 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Overview of pathologic features of Alzheimer’s disease.
Figure 1 Overview of pathologic features of Alzheimer’s disease.CC BY · PubMed Central
Figure 2 Comprehensive illustration of the interplay between the PI3K/PDK/Akt signaling pathway and the pathogenesis of Alzheimer’s disease. This figure delineates the activation and regulation of key components within the pathway, such as PI3K p85 and p110 subunits, PDK-1, and AKT, and their downstream effects on molecules such as GSK-3β, mTORC1, and the Wnt signaling components. The legend emphasizes the reciprocal modulation between these signaling molecules and the formation of Aβ and Tau oligomers, which are hallmarks of Alzheimer’s disease. The pathway’s dysregulation is implicated in the disease’s progression, affecting protein synthesis, proliferation, and autophagy. The figure also highlights the negative feedback mechanisms involving PTEN and the serine/threonine phosphorylation of AKT.
Figure 2 Comprehensive illustration of the interplay between the PI3K/PDK/Akt signaling pathway and the pathogenesis of Alzheimer’s disease. This figure delineates the activation and regulation of key components within the pathway, such as PI3K p85 and p110 subunits, PDK-1, and AKT, and their downstream effects on molecules such as GSK-3β, mTORC1, and the Wnt signaling components. The legend emphasizes the reciprocal modulation between these signaling molecules and the formation of Aβ and Tau oligomers, which are hallmarks of Alzheimer’s disease. The pathway’s dysregulation is implicated in the disease’s progression, affecting protein synthesis, proliferation, and autophagy. The figure also highlights the negative feedback mechanisms involving PTEN and the serine/threonine phosphorylation of AKT.CC BY · PubMed Central
Figure 3 Timeline figure of Alzheimer’s disease, indicating the role of PI3K and GSK3 and mice models in different stages.
Figure 3 Timeline figure of Alzheimer’s disease, indicating the role of PI3K and GSK3 and mice models in different stages.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 169 references

Cited by

See all 95

Metadata

Authors
Pan, J., Yao, Q., Wang, Y., Chang, S., Li, C., Wu, Y., Shen, J., & Yang, R.
Affiliations
  • Nantong University (CN)
  • Affiliated Hospital of Nantong University (CN)
Corresponding author
  • Shen, Jianhong
  • Yang, Riyun
Venue
Frontiers in Aging Neuroscience
Published
2024-09-27
Volume
16
Pages
1459025-1459025
ISSN
1663-4365 (ISSN-L)
OpenAlex
W4402958204
Cited by
89
References
169
Citations by year
2026: 47 · 2025: 42
FWCI
5.08
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Aging Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (YJXYY202204, 82101455)
  • Government of Jiangsu Province
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, PI3K/Akt signaling, amyloid-beta deposition, tau hyperphosphorylation, glycogen synthase kinase-3, neuroprotection, therapeutic target, herbal medicine, cognitive impairment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of PI3K signaling pathway in Alzheimer’s disease. https://app.cochat.ai/papers/10.3389/fnagi.2024.1459025
The paper
Pan, J., Yao, Q., Wang, Y., Chang, S., Li, C., Wu, Y., Shen, J., & Yang, R. (2024). The role of PI3K signaling pathway in Alzheimer’s disease. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2024.1459025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.